Skip to content
eHealthTutorial — Research Peptide Reviews
Preclinical • Not FDA-approved

Lys-Pro-Val intestinal inflammation research

KPV

KPV is a Lys-Pro-Val tripeptide studied in intestinal-cell systems and mouse colitis models. Those experiments do not establish an inflammatory-bowel-disease treatment in people.

Open calculator Explore the research
Generic research visual — not a commercial product
Compound typeThree-amino-acid Lys-Pro-Val peptide
Evidence baseCell and mouse studies; no established human trial
Regulatory contextInvestigational / Not FDA-approved
Page purposeResearch and calculation

Compound calculator

KPV reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Selected peptide or compoundKPV
Enter the total amount printed on the vial.
mL
Enter the liquid volume added in milliliters.
You provide this amount; the calculator does not select or recommend it.
Scale reference only; confirm the markings on the physical syringe.

Your KPV calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is KPV?

KPV is a short lysine-proline-valine peptide associated with the C-terminal region of alpha-melanocyte-stimulating hormone. A distinct derivative called KdPT and engineered KPV delivery systems also appear in literature; their results must not be assigned to plain KPV powder.

What has research examined?

A primary study examined PepT1-mediated KPV uptake in intestinal and immune cell systems and reported reduced inflammatory signals; its mouse colitis experiments also measured reduced inflammation under studied conditions. Later nanoparticle work used an engineered KPV delivery formulation, not a generic vial. FDA states it has not identified human exposure data for KPV drug products and lacks important safety information.

Important limitation

Mouse colitis and cell signaling findings cannot establish clinical IBD efficacy. Different delivery systems and modified peptides are not equivalent to plain KPV. A vial’s identity and human safety remain unvalidated, and this page makes no use recommendation.

Research references

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.